DEXTROGEL FAST ACTING DEXTROSE GEL 3 X 25G - 1 BOX

Product Information

We were assisted in a search of the Cochrane Neonatal Review Group Specialised Register. We undertook a search of MEDLINE, Embase, the Central Register of Controlled Trials (CENTRAL), the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Web of Science from inception of the database to 29 February 2016. We undertook a search of registries of clinical trials for any evidence of work in progress, or prior work planned, for which no results were published. We handsearched proceedings of relevant scientific meetings ‐ American Academy of Pediatrics (2000 to 2014), European Society for Pediatric Research (2006 to 2015), Perinatal Society of Australia and New Zealand (2002 to 2015). We applied no language restrictions.

We included two studies conducted in high‐income countries, involving 312 late preterm and at‐risk term infants and comparing oral dextrose gel (40% concentration) to placebo gel. One study was at low risk of bias, and the other (an abstract) was at unclear to high risk of bias. Oral dextrose gel compared with placebo gel probably increases correction of hypoglycaemic events (rate ratio 1.08, 95% confidence interval (CI) 0.98 to 1.20; rate difference 66 more per 1000, 95% CI 17 fewer to 166 more; 1 study; 237 infants; moderate‐certainty evidence), and may result in a slight reduction in the risk of major neurological disability at age two years or older, but the evidence is uncertain (risk ratio (RR) 0.46, 95% CI 0.09 to 2.47; risk difference (RD) 24 fewer per 1000, 95% CI 41 fewer to 66 more; 1 study, 185 children; low‐certainty evidence). The evidence is very uncertain about the effect of oral dextrose gel compared with placebo gel or no gel on the need for intravenous treatment for hypoglycaemia (RR 0.78, 95% CI 0.46 to 1.32; RD 37 fewer per 1000, 95% CI 91 fewer to 54 more; 2 studies, 312 infants; very low‐certainty evidence). Investigators in one study of 237 infants reported no adverse events (e.g. choking or vomiting at the time of administration) in the oral dextrose gel or placebo gel group (low‐certainty evidence). Blood glucose concentration was measured 30 minutes following gel treatment. Gel was repeated if hypoglycaemia persisted. A maximum of six doses of gel could be given within a 48‐hour period. Ovarian cancer is much rarer than breast cancer. Epidemiological evidence from a large meta-analysis suggests a slightly increased risk in women oestrogen-only or combined oestrogen-progestogen HRT which becomes apparent within 5 years of use and diminishes over time after stopping.There is no evidence from randomised controlled trials of protection against myocardial infarction in women with or without existing CAD who received combined oestrogen- progestogen or oestrogen-only HRT.

tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, Women who have never taken HRT and are post-menopausal or have very infrequent menstrual cycles : treatment with Oestrogel can be started on any day. Ovid MEDLINE(R) and Epub Ahead of Print, In‐Process, In‐Data‐Review & Other Non‐Indexed Citations, Daily and Versions(R)1946 to 5 October 2021 or/39‐48 [SR Filter: EMBASE based on CADTH filter: https://www‐cadth‐ca.ezproxy.uvm.edu/strings‐attached‐cadths‐database‐search‐filters] to consult a physician in case of signs and symptoms (breast development or other sexual changes) in a child that may have been exposed accidentally to Oestrogel.

More about glucose

Randomised controlled data found no increased risk of CAD in hysterectomised women using oestrogen-only therapy. There is some evidence of possible attrition bias because 26% of 36 infants in the control arm does not make up a whole number. integrative adj3 (review* or overview*)) or (collaborative adj3 (review* or overview*)) or (pool* adj3 analy*)).ti,ab,kw.

Harris DL, Gamble GD, Weston PJ, Harding JE. What happens to blood glucose concentrations after oral treatment for neonatal hypoglycemia? Journal of Pediatrics 2017; 190:136-41. [DOI: 10.1016/j.jpeds.2017.06.034] [ PubMed] [ CrossRef] [ Google Scholar] Neokay Drops is a preservative-free mono vitamin food supplement containing Vitamin K in fractionated coconut oil to prevent Vitamin K deficiency bleeding. The product is manufactured to GMP standards for supplementation to babies and does not contain artificial colors or flavors. If any of the following conditions are present, have occurred previously, and/or have been aggravated during pregnancy or previous hormone treatment, the patient should be closely supervised. It should be taken into account that these conditions may recur or be aggravated during treatment with Oestrogel, in particular:

Help page

A slightly greater number of mothers in the group allocated to oral dextrose gel than to placebo gel intended to breastfeed (114 of 115 vs 109 of 115). Weston P, Harris D, Harding J. Dextrose gel and formula but not breast milk are effective treatments for neonatal hypoglycaemia. Journal of Paediatrics and Child Health 2017; 53( Suppl 2):112. [DOI: 10.1111/jpc.13494_330] [ CrossRef] [ Google Scholar] Oestrogel was administered to 17 postmenopausal women once daily on the posterior surface of one arm from wrist to shoulder for 14 consecutive days.

In women with a uterus, use of oestrogen-only HRT is not recommended because it increases the risk of endometrial cancer (see section 4.4). Tell all of your health care providers that you take dextrose gel and liquid. This includes your doctors, nurses, pharmacists, and dentists. The randomised placebo-controlled trial, the Women's Health Initiative study (WHI), and a meta-analysis of prospective epidemiological studies are consistent in finding an increased risk of breast cancer in women taking combined oestrogen-progestogen for HRT that becomes apparent after about 3 (1-4) years (see Section 4.8).

What are some other side effects of Dextrose Gel and Liquid?

The following adverse reactions have also been reported in association with systemic oestrogen/ progestogen treatment: Two studies in high-income countries have assessed the use of oral dextrose gel to reverse low blood glucose levels in a total of 312 infants. Investigators rubbed oral dextrose gel into the inside of the infant's cheek for 157 of these infants and rubbed in placebo gel or no gel for 155 infants, and then gave a normal feed. The metabolism of oestrogens may be increased by concomitant use of substances known to induce drug-metabolising enzymes, specifically cytochrome P450 enzymes, such as anticonvulsants ( e.g. phenobarbital, phenytoin, carbamazepine) and anti- infectives ( e.g. rifampicin, rifabutin, nevirapine, efavirenz). Oestrogen deficiency at menopause is associated with an increasing bone turnover and decline in bone mass. Store in a cool and dark place (not in the refrigerator), keep out of the reach and sight of children.